Trial Profile
High or Low Dose Syntocinon (Oxytocin) for delay in labour.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2017
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Labour disorders
- Focus Therapeutic Use
- Acronyms HOLDS
- 21 May 2014 Accrual to date is 96% according to United Kingdom Clinical Research Network.
- 05 Oct 2011 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network record.
- 05 Oct 2011 Actual end date 17 Aug 2011 added as reported by United Kingdom Clinical Research Network record.